{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:48:55Z","timestamp":1782190135565,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jad.2026.121276","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:12:15Z","timestamp":1770016335000},"page":"121276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Experiences of Australian clinicians, researchers, and patients with MDMA-assisted psychotherapy for post-traumatic stress disorder: A framework-guided qualitative analysis"],"prefix":"10.1016","volume":"401","author":[{"given":"Alene Sze Jing","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aim\u00e9e","family":"Freeburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie","family":"Bratuskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillinder","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Simon","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121276_bb0005","series-title":"Critical realism for health and illness research: a practical introduction","author":"Alderson","year":"2021"},{"issue":"2","key":"10.1016\/j.jad.2026.121276_bb0010","article-title":"GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines","volume":"32","author":"Alonso-Coello","year":"2017","journal-title":"Gac. Sanit."},{"key":"10.1016\/j.jad.2026.121276_bb0015","article-title":"GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ."},{"key":"10.1016\/j.jad.2026.121276_bb0020","unstructured":"Phoenix Australia (2020) Australian Guidelines for the Treatment of Acute Stress Disorder, Posttraumatic Stress Disorder, and Complex PTSD."},{"key":"10.1016\/j.jad.2026.121276_bb0025","series-title":"Stress and trauma. Reportno. Report Number|, Date. Place Published|: Institution","author":"Australian Institute of Health and Welfare","year":"2024"},{"issue":"3","key":"10.1016\/j.jad.2026.121276_bb0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/02791072.2021.1957183","article-title":"Psychedelic knowledge and opinions in psychiatrists at two professional conferences: an exploratory survey","volume":"54","author":"Barnett","year":"2022","journal-title":"J. Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.jad.2026.121276_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/02791072.2019.1580805","article-title":"Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD","volume":"51","author":"Barone","year":"2019","journal-title":"J. Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.jad.2026.121276_bb0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/00048674221127186","article-title":"MDMA-assisted psychotherapy for post-traumatic stress disorder: the devil is in the detail","volume":"57","author":"Bedi","year":"2023","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2026.121276_bb0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/10398562231156684","article-title":"The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists","volume":"31","author":"Berger","year":"2023","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.jad.2026.121276_bb0050","series-title":"\u2018Serious concerns\u2019 over TGA\u2019s decision making on landmark psilocybin, MDMA ruling. ABC News, 18 Mar 2023","author":"Blau","year":"2023"},{"key":"10.1016\/j.jad.2026.121276_bb0055","series-title":"Thematic analysis: a practical guide","author":"Braun","year":"2021"},{"issue":"9","key":"10.1016\/j.jad.2026.121276_bb0060","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","article-title":"Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies","volume":"34","author":"Breeksema","year":"2020","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.jad.2026.121276_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/02791072.2021.1971343","article-title":"Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States","volume":"54","author":"Davis","year":"2022","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jad.2026.121276_bb0070","series-title":"Guide to good prescribing: a practical manual","author":"De Vries","year":"1994"},{"issue":"2","key":"10.1016\/j.jad.2026.121276_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae024","article-title":"A mixed-methods study on the pharmacological management of pain in Australian and Japanese nursing homes","volume":"53","author":"Dowd","year":"2024","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.jad.2026.121276_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13645579.2016.1144401","article-title":"Applying critical realism in qualitative research: methodology meets method","volume":"20","author":"Fletcher","year":"2017","journal-title":"Int. J. Soc. Res. Methodol."},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2026.121276_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1556\/2054.2023.00267","article-title":"Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials","volume":"7","author":"Harrison","year":"2023","journal-title":"Journal of Psychedelic Studies"},{"issue":"1","key":"10.1016\/j.jad.2026.121276_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/20008066.2024.2378651","article-title":"Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation","volume":"15","author":"Herpers","year":"2024","journal-title":"Eur. J. Psychotraumatol."},{"issue":"7","key":"10.1016\/j.jad.2026.121276_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-006303","article-title":"Global burden of post-traumatic stress disorder and major depression in countries affected by war between 1989 and 2019: a systematic review and meta-analysis","volume":"6","author":"Hoppen","year":"2021","journal-title":"BMJ Glob. Health"},{"issue":"13","key":"10.1016\/j.jad.2026.121276_bb0100","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1017\/S0033291717000708","article-title":"Posttraumatic stress disorder in the World Mental Health Surveys","volume":"47","author":"Koenen","year":"2017","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.jad.2026.121276_bb0105","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/cpp.2880","article-title":"Psychologists\u2019 and psychotherapists\u2019 knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics","volume":"30","author":"Kucsera","year":"2023","journal-title":"Clin. Psychol. Psychother."},{"issue":"1","key":"10.1016\/j.jad.2026.121276_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/inm.70010","article-title":"The acceptability of psychedelic-assisted therapy amongst mental health consumers: utilising the theory of planned behaviour","volume":"34","author":"Louie","year":"2025","journal-title":"Int. J. Ment. Health Nurs."},{"key":"10.1016\/j.jad.2026.121276_bb0115","unstructured":"Lucas F (2025) Psychedelic therapy may soon be funded for veterans with PTSD, depression. ABC News, 4 March 2025."},{"key":"10.1016\/j.jad.2026.121276_bb0120","first-page":"14","author":"Lumivero","year":"2023","journal-title":"NVivo"},{"issue":"1","key":"10.1016\/j.jad.2026.121276_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/psymed.2023.0033","article-title":"Getting in Touch with Touch: The Importance of Studying Touch in MDMA-Assisted Therapy and the Development of a New Self-Report Measure","volume":"2","author":"Luoma","year":"2024","journal-title":"Psychedelic Medicine"},{"issue":"13","key":"10.1016\/j.jad.2026.121276_bb0130","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample Size in Qualitative Interview Studies: Guided by Information Power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual. Health Res."},{"issue":"5","key":"10.1016\/j.jad.2026.121276_bb0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamapsychiatry.2023.0099","article-title":"Studying Harms Is Key to Improving Psychedelic-Assisted Therapy\u2014Participants Call for Changes to Research Landscape","volume":"80","author":"McNamee","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121276_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2025.0695","article-title":"Loss of PTSD Diagnosis in Response to Evidence-Based Treatments: A Systematic Review and Meta-Analysis","author":"Milligan","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121276_bb0145","unstructured":"Mithoefer MC (2017) A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder. Reportno. Report Number|, Date. Place Published|: Institution|."},{"issue":"11","key":"10.1016\/j.jad.2026.121276_bb0150","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/00048674221081763","article-title":"The challenges ahead for psychedelic \u2018medicine\u2019","volume":"56","author":"Muthukumaraswamy","year":"2022","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2026.121276_bb0155","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/00048674241261779","article-title":"Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia","volume":"58","author":"Nadeem","year":"2024","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"0","key":"10.1016\/j.jad.2026.121276_bb0160","article-title":"Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers","volume":"0","author":"Nadeem","year":"2025","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.121276_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/15265161.2024.2433428","article-title":"Supportive Touch in Psychedelic Assisted Therapy","volume":"25","author":"Neitzke-Spruill","year":"2025","journal-title":"Am. J. Bioeth."},{"key":"10.1016\/j.jad.2026.121276_bb0170","doi-asserted-by":"crossref","unstructured":"Page LA, Rehman A, Syed H, et al. (2021) The readiness of psychiatrists to implement psychedelic-assisted psychotherapy. Front. Psych. 12: 743599, Front. Psychiatry.","DOI":"10.3389\/fpsyt.2021.743599"},{"key":"10.1016\/j.jad.2026.121276_bb0175","series-title":"Clinical Memorandum: Therapeutic use of MDMA for PTSD and psilocybin for treatment resistant depression. Reportno","article-title":"Report Number|, Date. Place Published|: Institution|","author":"Royal Australian and New Zealand College of Psychiatrists","year":"2023"},{"issue":"4","key":"10.1016\/j.jad.2026.121276_bb0180","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: exploring its conceptualization and operationalization","volume":"52","author":"Saunders","year":"2018","journal-title":"Qual. Quant."},{"key":"10.1016\/j.jad.2026.121276_bb0185","doi-asserted-by":"crossref","unstructured":"Schwartzkopff L, Gutermann J, Steil R, et al. (2021) Which trauma treatment suits me? Identification of patients' treatment preferences for posttraumatic stress disorder (PTSD). Front. Psychol. 12: 694038.","DOI":"10.3389\/fpsyg.2021.694038"},{"issue":"10","key":"10.1016\/j.jad.2026.121276_bb0190","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1016\/S2666-7568(22)00186-6","article-title":"Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England","volume":"3","author":"Tan","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.jad.2026.121276_bb0195","series-title":"Update on MDMA and psilocybin access and safeguards from 1 July 2023","author":"Therapeutic Goods Administration","year":"2023"},{"issue":"6","key":"10.1016\/j.jad.2026.121276_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int. J. Qual. Health Care"},{"key":"10.1016\/j.jad.2026.121276_bb0205","doi-asserted-by":"crossref","DOI":"10.1556\/2054.2023.00294","article-title":"Perceptions and attitudes towards psychedelic-assisted psychotherapy among health professionals, patients, and the public: a systematic review","author":"Wells","year":"2024","journal-title":"J. Psychedelic Stud."},{"issue":"4","key":"10.1016\/j.jad.2026.121276_bb0210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/00048674251315642","article-title":"Safety and efficacy of methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in post-traumatic stress disorder: an overview of systematic reviews and meta-analyses","volume":"59","author":"Yong","year":"2025","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121276_bb0215","unstructured":"Yong ASJ, Brennan SE, Bratuskins S, et al. (2025b) Clinical Practice Guidelines for the Appropriate Use of MDMA-Assisted Psychotherapy for Post-traumatic Stress Disorder. Available at: https:\/\/app.magicapp.org\/#\/guideline\/Ee438n."},{"key":"10.1016\/j.jad.2026.121276_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119866","article-title":"Development of an Australian clinical practice guideline on methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder","author":"Yong","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121276_bb0225","doi-asserted-by":"crossref","unstructured":"Chen JA, Keller SM, Zoellner LA, et al. (2013) \"How will it help me?\" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder. J. Nerv. Ment. Dis. 201(8): 691\u2013697.","DOI":"10.1097\/NMD.0b013e31829c50a9"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:17:14Z","timestamp":1782188234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"alternative-id":["S0165032726001278"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121276","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experiences of Australian clinicians, researchers, and patients with MDMA-assisted psychotherapy for post-traumatic stress disorder: A framework-guided qualitative analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121276"}}